One such commonly used medication for dermatologic and rheumatologic inflammatory conditions is hydroxychloroquine (Plaquenil), a chloroquine derivative. It is used to treat many diseases including malaria, rheumatoid arthritis and systemic lupus erythematosus. Plaquenil false positive Taking plaquenil can i drink alcohol 30-2 plaquenil What drug is similiar to plaquenil Plaquenil Toxicity - Bulls Eye Maculopathy 575 views 70-year-old woman with systemic Lupus erythematosus and clotting problems. She was on the Plaquenil for about eight years and then off the Plaquenil for the last eight years because she developed macular toxicity. Although her vision was hazy, it was stable. Find patient medical information for Plaquenil Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Follow The GuidesCase OneCase TwoScreening ProtocolSigns It is imperative that patients and physicians are aware of and watch for this drug’s ocular side effects. Retinal toxicity from hydroxychloroquine is rare, but even if the medication is discontinued, vision loss may be irreversible and may continue to progress. Plaquenil maculopathy photos Plaquenil-Induced Toxic Maculopathy - Decision-Maker PLUS, Plaquenil Oral Uses, Side Effects, Interactions. Plaquenil pulmonary sarcoidosisCan plaquenil help skin cancerPlaquenil trouble swallowing Today it is recommended that every single person on Plaquenil get a visual field 10-2 test, plus one of the three other highly sensitive screening tests the FAF fundus autofluorescence imaging, the SD-OCT spectral domain optical coherence, or the multifocal electroretinogram mfERG,” Thomas says. Protecting your eyesight when taking Plaquenil Lupus.. How to Succeed in Plaquenil Screenings. Plaquenil Toxicity - Mild - Partial Bull's Eye Maculopathy.. History of Present IllnessOcular ExaminationDiscussionFull Clinical History and CourseDifferential Diagnosis Symptoms and SignsMechanism of ToxicityMedication DosageRisk For ToxicityMonitoring GuidelinesConclusion Background The American Academy of Ophthalmology recommendations on screening for chloroquine CQ and hydroxychloroquine HCQ retinopathy are revised in light of new information about the prevalence of toxicity, risk factors, fundus distribution, and effectiveness of screening tools.